vs
Side-by-side financial comparison of Ladder Capital Corp (LADR) and Sight Sciences, Inc. (SGHT). Click either name above to swap in a different company.
Ladder Capital Corp is the larger business by last-quarter revenue ($22.3M vs $20.4M, roughly 1.1× Sight Sciences, Inc.). Ladder Capital Corp runs the higher net margin — 71.0% vs -20.4%, a 91.5% gap on every dollar of revenue. On growth, Sight Sciences, Inc. posted the faster year-over-year revenue change (6.9% vs -18.0%). Ladder Capital Corp produced more free cash flow last quarter ($78.7M vs $-2.0M). Over the past eight quarters, Sight Sciences, Inc.'s revenue compounded faster (2.9% CAGR vs -22.5%).
Ladder Capital Corp is a leading commercial real estate finance firm operating primarily across the United States. It originates and manages a diversified portfolio of senior secured commercial mortgage loans, mezzanine debt, commercial mortgage-backed securities, and direct real estate assets, serving property owners, operators and developers across major market segments.
Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.
LADR vs SGHT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $22.3M | $20.4M |
| Net Profit | $15.9M | $-4.2M |
| Gross Margin | — | 87.3% |
| Operating Margin | 69.5% | -18.0% |
| Net Margin | 71.0% | -20.4% |
| Revenue YoY | -18.0% | 6.9% |
| Net Profit YoY | -49.4% | 64.9% |
| EPS (diluted) | $0.13 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $22.3M | $20.4M | ||
| Q3 25 | $27.8M | $19.9M | ||
| Q2 25 | $21.5M | $19.6M | ||
| Q1 25 | $20.3M | $17.5M | ||
| Q4 24 | $27.2M | $19.1M | ||
| Q3 24 | $38.4M | $20.2M | ||
| Q2 24 | $34.3M | $21.4M | ||
| Q1 24 | $37.1M | $19.3M |
| Q4 25 | $15.9M | $-4.2M | ||
| Q3 25 | $19.2M | $-8.2M | ||
| Q2 25 | $17.1M | $-11.9M | ||
| Q1 25 | $11.6M | $-14.2M | ||
| Q4 24 | $31.3M | $-11.8M | ||
| Q3 24 | $27.6M | $-11.1M | ||
| Q2 24 | $32.1M | $-12.3M | ||
| Q1 24 | $16.4M | $-16.3M |
| Q4 25 | — | 87.3% | ||
| Q3 25 | — | 86.4% | ||
| Q2 25 | — | 84.8% | ||
| Q1 25 | — | 86.2% | ||
| Q4 24 | — | 86.8% | ||
| Q3 24 | — | 83.9% | ||
| Q2 24 | — | 85.8% | ||
| Q1 24 | — | 85.5% |
| Q4 25 | 69.5% | -18.0% | ||
| Q3 25 | 72.4% | -39.7% | ||
| Q2 25 | 96.7% | -59.6% | ||
| Q1 25 | 52.7% | -79.2% | ||
| Q4 24 | — | -62.5% | ||
| Q3 24 | 74.1% | -55.7% | ||
| Q2 24 | 90.4% | -59.2% | ||
| Q1 24 | 49.4% | -76.4% |
| Q4 25 | 71.0% | -20.4% | ||
| Q3 25 | 69.0% | -41.0% | ||
| Q2 25 | 79.5% | -61.0% | ||
| Q1 25 | 56.8% | -80.8% | ||
| Q4 24 | 115.1% | -62.1% | ||
| Q3 24 | 71.7% | -54.9% | ||
| Q2 24 | 93.6% | -57.7% | ||
| Q1 24 | 44.2% | -84.4% |
| Q4 25 | $0.13 | $-0.07 | ||
| Q3 25 | $0.15 | $-0.16 | ||
| Q2 25 | $0.14 | $-0.23 | ||
| Q1 25 | $0.09 | $-0.28 | ||
| Q4 24 | $0.25 | $-0.23 | ||
| Q3 24 | $0.22 | $-0.22 | ||
| Q2 24 | $0.26 | $-0.25 | ||
| Q1 24 | $0.13 | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $38.0M | $92.0M |
| Total DebtLower is stronger | — | $42.4M |
| Stockholders' EquityBook value | $1.5B | $63.9M |
| Total Assets | $5.2B | $115.3M |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $38.0M | $92.0M | ||
| Q3 25 | $49.4M | $92.4M | ||
| Q2 25 | $134.9M | $101.5M | ||
| Q1 25 | $479.8M | $108.8M | ||
| Q4 24 | $1.3B | $120.4M | ||
| Q3 24 | $1.6B | $118.6M | ||
| Q2 24 | $1.2B | $118.2M | ||
| Q1 24 | $1.2B | $127.3M |
| Q4 25 | — | $42.4M | ||
| Q3 25 | — | $42.4M | ||
| Q2 25 | — | $42.4M | ||
| Q1 25 | — | $42.4M | ||
| Q4 24 | — | $40.0M | ||
| Q3 24 | — | $37.1M | ||
| Q2 24 | — | $35.0M | ||
| Q1 24 | — | $35.0M |
| Q4 25 | $1.5B | $63.9M | ||
| Q3 25 | $1.5B | $64.3M | ||
| Q2 25 | $1.5B | $70.0M | ||
| Q1 25 | $1.5B | $77.6M | ||
| Q4 24 | $1.5B | $87.5M | ||
| Q3 24 | $1.5B | $95.0M | ||
| Q2 24 | $1.5B | $101.6M | ||
| Q1 24 | $1.5B | $109.2M |
| Q4 25 | $5.2B | $115.3M | ||
| Q3 25 | $4.7B | $116.3M | ||
| Q2 25 | $4.5B | $122.0M | ||
| Q1 25 | $4.5B | $129.7M | ||
| Q4 24 | $4.8B | $142.8M | ||
| Q3 24 | $4.8B | $143.6M | ||
| Q2 24 | $4.8B | $149.7M | ||
| Q1 24 | $5.3B | $155.6M |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.66× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | 0.46× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.32× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $87.0M | $-1.8M |
| Free Cash FlowOCF − Capex | $78.7M | $-2.0M |
| FCF MarginFCF / Revenue | 352.4% | -9.7% |
| Capex IntensityCapex / Revenue | 37.4% | 0.8% |
| Cash ConversionOCF / Net Profit | 5.49× | — |
| TTM Free Cash FlowTrailing 4 quarters | $118.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $87.0M | $-1.8M | ||
| Q3 25 | $26.3M | $-8.7M | ||
| Q2 25 | $44.0M | $-7.5M | ||
| Q1 25 | $-28.7M | $-11.6M | ||
| Q4 24 | $133.9M | $-3.5M | ||
| Q3 24 | $169.0M | $362.0K | ||
| Q2 24 | $45.4M | $-9.5M | ||
| Q1 24 | $-20.4M | $-9.8M |
| Q4 25 | $78.7M | $-2.0M | ||
| Q3 25 | $25.9M | $-8.9M | ||
| Q2 25 | $43.4M | $-7.8M | ||
| Q1 25 | $-29.6M | — | ||
| Q4 24 | $127.4M | $-3.6M | ||
| Q3 24 | $166.0M | $311.0K | ||
| Q2 24 | $44.9M | $-9.5M | ||
| Q1 24 | $-21.7M | $-9.9M |
| Q4 25 | 352.4% | -9.7% | ||
| Q3 25 | 93.1% | -44.7% | ||
| Q2 25 | 201.6% | -39.6% | ||
| Q1 25 | -145.6% | — | ||
| Q4 24 | 468.2% | -18.9% | ||
| Q3 24 | 432.1% | 1.5% | ||
| Q2 24 | 131.0% | -44.7% | ||
| Q1 24 | -58.6% | -51.4% |
| Q4 25 | 37.4% | 0.8% | ||
| Q3 25 | 1.7% | 0.9% | ||
| Q2 25 | 2.9% | 1.1% | ||
| Q1 25 | 4.3% | 0.0% | ||
| Q4 24 | 23.9% | 0.7% | ||
| Q3 24 | 7.8% | 0.3% | ||
| Q2 24 | 1.3% | 0.4% | ||
| Q1 24 | 3.7% | 0.6% |
| Q4 25 | 5.49× | — | ||
| Q3 25 | 1.37× | — | ||
| Q2 25 | 2.57× | — | ||
| Q1 25 | -2.49× | — | ||
| Q4 24 | 4.27× | — | ||
| Q3 24 | 6.13× | — | ||
| Q2 24 | 1.41× | — | ||
| Q1 24 | -1.24× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LADR
Segment breakdown not available.
SGHT
| Surgical Glaucoma | $19.7M | 96% |
| Other | $724.0K | 4% |
